Having difficult conversations with patients is part of practicing medicine. However, according to SERMO – the largest global social network for doctors with more than 600,000 members worldwide – certain topics are more uncomfortable for doctors to discuss than others.
Eagle Pharmaceuticals Inc. announced that it has completed the submission of its 505(b)(2) New Drug Application for Ryanodex for the treatment of exertional heat stroke (EHS) to the U.S. Food and Drug Administration.
University of Missouri researchers have found that luteolin, a natural compound found in herbs such as thyme and parsley, and vegetables such as celery and broccoli, could reduce the risk of developing metastasis originating from triple-negative breast cancer in women.
Bristol-Myers Squibb and Ono Pharmaceutical announced a global patent license agreement with Merck & Co. to settle all patent-infringement litigation related to Merck’s PD-1 antibody Keytruda.
Espero Pharmaceuticals Inc., a commercial-stage cardiovascular pharmaceutical company, will donate GONITRO (nitroglycerin sublingual powder) to the ongoing International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) clinical trial and to the ISCHEMIA-Chronic Kidney Disease (CKD) ancillary trial.
Digital Health solutions are still mostly driven by marketing departments, whether they be novel devices that alter the way we treat rare diseases or commonplace wearable bands that track our activity.
FCB Health CEO Dana Maiman announced that Joe Soto and Steven Hebert have been appointed to the roles of Co-Managing Directors for FCBCure, the company’s N.J. office.
Celine Vita, a former executive at CDM, has been appointed president of Centron’s advertising division.
McCann Health, the most creatively awarded global health communications network and the 2016 Cannes Lions “Health Network of the Year,” announced the appointment of Geline Midouin to Global Chief Talent Officer.
